Lurtotecan is a semi-synthetic analog of camptothecin with antineoplastic activity. Liposomal lurtotecan was in clinical trials as a treatment for topotecan -resistant ovarian cancer ,[ 1] but was discontinued.[ 2]
Quick facts Names, Identifiers ...
Lurtotecan
Names
Preferred IUPAC name
(8S )-8-Ethyl-8-hydroxy-15-[(4-methylpiperazin-1-yl)methyl]-2,3-dihydro-11H -[1,4]dioxino[2,3-g ]pyrano[3′,4′:6,7]indolizino[1,2-b ]quinoline-9,12(8H ,14H )-dione
Identifiers
ChEMBL
ChemSpider
UNII
InChI=1S/C28H30N4O6/c1-3-28(35)20-11-22-25-18(14-32(22)26(33)19(20)15-38-27(28)34)17(13-31-6-4-30(2)5-7-31)16-10-23-24(12-21(16)29-25)37-9-8-36-23/h10-12,35H,3-9,13-15H2,1-2H3/t28-/m0/s1 Y
Key: RVFGKBWWUQOIOU-NDEPHWFRSA-N Y
InChI=1/C28H30N4O6/c1-3-28(35)20-11-22-25-18(14-32(22)26(33)19(20)15-38-27(28)34)17(13-31-6-4-30(2)5-7-31)16-10-23-24(12-21(16)29-25)37-9-8-36-23/h10-12,35H,3-9,13-15H2,1-2H3/t28-/m0/s1
Key: RVFGKBWWUQOIOU-NDEPHWFRBI
O=C2OCC=1C(=O)N6/C(=C\C=1[C@@]2(O)CC)c5nc4cc3OCCOc3cc4c(c5C6)CN7CCN(C)CC7
Properties
C28 H30 N4 O6
Molar mass
518.561 g/mol
Except where otherwise noted, data are given for materials in their
standard state (at 25
°C [77
°F], 100
kPa).
Close